Day Zero Antivirals and Preventing the Next Pandemic - with Special Guest Dr. Brian Wang

In this episode we are joined by Scientist and Researcher Dr. Brian Wang to discuss the work he and his colleagues are pursuing at Panoplia Laboratories in Cambridge MA. Dr. Wang and his team are in pursuit of Broad Spectrum Antivirals that can be available on day zero of the next pandemic. We discuss the methods of bioengineering that Panoplia Labs will be using, including the use of synthetic biology to aid the body's own immune system against viruses. We also discuss the possible routes of administration, as well as the barriers and timelines associated with this innovative and remarkable biotechnology. You won't want to miss this fascinating and informative episode.Our guest Dr. Brian Wang is the co founder and executive director of Panoplia Laboratories in Cambridge MA. Brian was also the prior head of research and development at the biotech company Alvea, Dr. Wang completed his postdoctoral education at Massachusetts Institute of Technology and completed his graduate studies at UC Berkley and received his undergraduate degree from Cornell University. Brian has been published in Nature Communications, The Journal of the American Chemical Society, and Angewandte Chemie International Edition. He is the owner if multiple patents and has been the recipient of the Emergent Ventures Fellowship from The Mercatus Center as well as the National Science Foundation Fellowship from the National Science Foundation.